LARISSA GONZALEZ: Open Payments
NPI 1811461106 · ORANGE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,026 in 134 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $2,969 · 2025 $3,026
Food & beverage: $3,026
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 13 | $524 |
| ABBVIE INC. | 22 | $501 |
| Otsuka America Pharmaceutical, Inc. | 13 | $301 |
| Vanda Pharmaceuticals Inc. | 14 | $287 |
| Neurocrine BioSciences, Inc. | 8 | $268 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 17 | $266 |
| Alkermes, Inc. | 11 | $251 |
| Lundbeck LLC | 11 | $167 |
| Teva Pharmaceuticals USA, Inc. | 9 | $138 |
| Axsome Therapeutics, Inc. | 4 | $109 |
Products named: VRAYLAR, SPRAVATO, REXULTI, FANAPT, INGREZZA, CAPLYTA, ARISTADA, AUSTEDO XR.
Industry payments across CA — which companies pay providers there.
